Oxford Asset Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-21,451
| Closed | -$80.4K | – | 385 |
|
|
2024
Q1 | $80.4K | Buy |
+21,451
| New | +$80.4K | 0.08% | 229 |
|
|
2019
Q3 | – | Sell |
-249,530
| Closed | -$1.51M | – | 1889 |
|
|
2019
Q2 | $1.51M | Sell |
249,530
-647,993
| -72% | -$3.92M | 0.03% | 775 |
|
|
2019
Q1 | $6.49M | Buy |
897,523
+250,000
| +39% | +$1.81M | 0.14% | 161 |
|
|
2018
Q4 | $4.79M | Buy |
647,523
+569,253
| +727% | +$4.21M | 0.12% | 184 |
|
|
2018
Q3 | $434K | Buy |
+78,270
| New | +$434K | 0.01% | 1357 |
|
|
2016
Q3 | – | Sell |
-31,630
| Closed | -$223K | – | 829 |
|
|
2016
Q2 | $223K | Sell |
31,630
-228,502
| -88% | -$1.61M | 0.01% | 679 |
|
|
2016
Q1 | $2.21M | Buy |
260,132
+100,560
| +63% | +$855K | 0.06% | 354 |
|
|
2015
Q4 | $2.2M | Buy |
+159,572
| New | +$2.2M | 0.05% | 376 |
|
|
2015
Q3 | – | Sell |
-256,891
| Closed | -$1.48M | – | 701 |
|
|
2015
Q2 | $1.48M | Sell |
256,891
-46,091
| -15% | -$266K | 0.04% | 388 |
|
|
2015
Q1 | $1.77M | Buy |
+302,982
| New | +$1.77M | 0.05% | 385 |
|
|
2014
Q3 | – | Sell |
-162,095
| Closed | -$1M | – | 734 |
|
|
2014
Q2 | $1M | Sell |
162,095
-421,522
| -72% | -$2.6M | 0.03% | 487 |
|
|
2014
Q1 | $3.12M | Buy |
+583,617
| New | +$3.12M | 0.09% | 289 |
|